Maple Syrup Urine Disease
📧 Sign up to get email alerts when something new happens for Maple Syrup Urine Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-09-30EMA Authorised: Maapliv (glycine,L-alanine,L-arginine,L-aspartic acid,L-cysteine hydrochloride monohydrate,L-histidine,L-methionine,L-phenylalanine,L-proline,L-serine,L-threonine,L-tryptophan,L-tyrosine,L-glutamic acid,L-lysine monohydrate,taurine) — Recordati Rare Diseases
EMA authorised Maapliv for Maple Syrup Urine Disease, an amino-acid based product developed for an orphan indication by Recordati Rare Disea…